Cell Works Inc.
This article was originally published in Start Up
Executive SummaryCell Works Inc.'s Circulating Cancer Cell Test can detect and characterize tumor cells in blood by separating cancer cells from the rest of the sample and scanning them in its automated microscope system. Cell Works hopes that its non-invasive tests will enable earlier disease intervention, and that its forthcoming informatics program will serve as a springboard into the prognostics and therapeutics arenas.
You may also be interested in...
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)